Although these findings are instructive, the ability of CXCR3+ T lymphocytes and NK cells to exert endogenous tumor control may be compromised if there is long-term systemic antagonism of CXCR3 in the body’s internal environment. This evidence concerns the gene CXCR3 and neoplasm.